Menlo Park, CA, United States of America

Xin Eric Zhang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Akso Biopharmaceutical, Inc., Leland Stanford Junior University. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Eric Zhang. Retrieved from https://idiyas.com/inventor/xin-eric-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xin Eric Zhang

Introduction

Xin Eric Zhang is an accomplished inventor based in Menlo Park, CA. He is known for his significant contributions to the field of biopharmaceuticals. His work has led to the development of novel therapeutic proteins that have the potential to impact medical treatments.

Latest Patents

Xin Eric Zhang holds a patent for the invention titled "SPD-1 variant# FC fusion proteins." This invention is directed to novel sPD-1 variant—Fc fusion proteins, which are designed to enhance therapeutic efficacy.

Career Highlights

Throughout his career, Zhang has worked with prestigious institutions, including Leland Stanford Junior University and Akso Biopharmaceutical, Inc. His experience in these organizations has allowed him to refine his expertise in biopharmaceutical research and development.

Collaborations

Zhang has collaborated with notable professionals in his field, including Amato J Giaccia and Todd A Aguilera. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Xin Eric Zhang's work exemplifies the spirit of innovation in the biopharmaceutical industry. His contributions, particularly in the development of fusion proteins, highlight the importance of research in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…